CollPlant Biotechnologies (CLGN) Other Accumulated Expenses (2018 - 2025)

CollPlant Biotechnologies (CLGN) has 6 years of Other Accumulated Expenses data on file, last reported at $62000.0 in Q4 2025.

• Quarterly Other Accumulated Expenses fell 38.61% year-over-year to $62000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62000.0 (down 38.61% YoY) and the FY2025 annual result came in at $62000.0, down 38.61% from the prior year.
• Other Accumulated Expenses declined to $62000.0 in Q4 2025, from $101000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $105000.0 in Q4 2023 to a low of $53000.0 in Q4 2022.
• A 4-year average of $80250.0 and a median of $81500.0 in 2024 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses jumped 98.11% — and 2025, when it slumped 38.61%.
• Tracing CLGN's Other Accumulated Expenses over 4 years: stood at $53000.0 in 2022, then jumped by 98.11% to $105000.0 in 2023, then slipped by 3.81% to $101000.0 in 2024, then tumbled by 38.61% to $62000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $62000.0 (Q4 2025), $101000.0 (Q4 2024), and $105000.0 (Q4 2023), per Business Quant data.